Personalized medicine: A personal view

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 3, 2012, Pages 373-375

  Meyer, U A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CONSUMER; CONSUMER GENOMICS; DIAGNOSTIC TEST; DRUG RESPONSE; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; GENOTYPE; HEALTH CARE COST; HUMAN; MOLECULAR DIAGNOSIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW;

GENETIC VARIATION; GENOME, HUMAN; HEALTH; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACEUTICAL PREPARATIONS;

EID: 84857225564     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.238     Document Type: Review

References (7)

1. Human genome: genomes by the thousand. Nature 467, 1026-1027 (2010).
2. Ashley, E.H. et al. Clinical assessment incorporating a personal genome. Lancet 375, 1525-1535 (2010).
3. Mullard, A. 2010 FDA drug approvals. Nat. Rev. Drug Discov. 10, 82-85 (2011).
4. Arrowsmith, J. Phase III and submission failures: 2007-2010. Nat. Rev. Drug Discov. 10, 87 (2011).
5. Greely, H.T. Get ready for the flood of fetal gene screening. Nature 469, 289-291 (2011).
6. Meyer, U.A. Pharmacogenetics-five decades of therapeutic lessons from genetic diversity. Nat. Rev. Genet. 5, 669-675 (2004).
7. Getting personal. Nature 473, 253-254 (2011).